Domov › Rakovina prsníka › Kalifornia › Orange
Klinické štúdie Rakovina prsníka v meste Orange, CA
14 štúdií pre Rakovina prsníka hľadá účastníkov v zariadeniach v meste Orange a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Prebieha náborFáza 3
- UC Irvine Medical Center, Orange
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Prebieha náborFáza 1/2
- University of California Irvine, Orange
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Prebieha náborFáza 2
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
Prebieha náborFáza 2
- Community Clinical Trials, Orange
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Prebieha náborFáza 3
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Prebieha náborFáza 3
- UC Irvine Health, Chao Family Comprehensive Cancer Center, Orange
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Prebieha náborFáza 3
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
E-Mindfulness Approaches for Living After Breast Cancer
Prebieha náborFáza 3
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Prebieha náborFáza 2
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Prebieha náborFáza 1/2
- UC Irvine Health-Chao Family Comprehensive Cancer Center, Orange
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Prebieha náborFáza 3
- Saint Joseph Hospital - Orange, Orange
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
Prebieha náborFáza 2
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Prebieha náborFáza 2
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Orange
Štúdie Rakovina prsníka v iných mestách
- New York City, NY136 štúdií
- Houston, TX126 štúdií
- Boston, MA112 štúdií
- Nashville, TN81 štúdií
- Los Angeles, CA73 štúdií
- Edison, NJ68 štúdií
- St. Louis, MO64 štúdií
- Queens, NY64 štúdií
- Durham, NC64 štúdií
- Chicago, IL59 štúdií
- Philadelphia, PA56 štúdií
- Dallas, TX55 štúdií
Iné štúdie v Orange
- Nemalobunkový karcinóm pľúc25 štúdií
- Metastatická rakovina20 štúdií
- Kolorektálny karcinóm16 štúdií
- Rakovina vaječníkov16 štúdií
- Rakovina pankreasu15 štúdií
- Melanóm14 štúdií
- Rakovina pečene (hepatocelulárny karcinóm)14 štúdií
- Rakovina pľúc14 štúdií
- Rakovina prostaty14 štúdií
- Rakovina žalúdka13 štúdií
- Rakovina (všetky typy)13 štúdií
- Akútna myeloidná leukémia13 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.